Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONCY Putting It's Best Foot Forward

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Mar 15, 2023 9:22am

153 Views

Post# 35339340

RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY Putting It's Best Foot Forward

To me, and I'm bullish, seemingly being so close to the finish line & in serious multi party negotiations with much of the intended audience of these fluff pieces, now is not the right time to release one. It doesn't really inspire much confidence, and if the intended effect is to get the SP marching upwards, here's a better idea: NR's involving accelerated approval or priority review for mBC & panc. Those need to be released...LET'S GO!!!

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures